Following peripheral nerve injury, transient receptor potential vanilloid 4 (TRPV4) is upregulated, resulting in the release of lipocalin-2 (LCN2), which contributes to enhanced pain sensitivity [85]. The gene discussed is LCN2; the disease is peripheral nerve injury.